These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37726978)

  • 41. A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial.
    Vaughan EM; Hyman DJ; Naik AD; Samson SL; Razjouyan J; Foreyt JP
    J Gen Intern Med; 2021 Feb; 36(2):455-463. PubMed ID: 32700217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A cross-sectional observational study.
    Sartore G; Caprino R; Ragazzi E; Lapolla A
    PLoS One; 2023; 18(2):e0269350. PubMed ID: 36791131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telemedicine for Disparity Patients With Diabetes: The Feasibility of Utilizing Telehealth in the Management of Uncontrolled Type 2 Diabetes in Black and Hispanic Disparity Patients; A Pilot Study.
    Myers A; Presswala L; Bissoonauth A; Gulati N; Zhang M; Izard S; Kozikowski A; Meyers K; Pekmezaris R
    J Diabetes Sci Technol; 2021 Sep; 15(5):1034-1041. PubMed ID: 32865027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the effect of COVID-19 on quality measures of patients with type 2 diabetes in two family nurse practitioner-owned clinics.
    Wright WL; White PA; Welsh M; Cutting K
    J Am Assoc Nurse Pract; 2022 Sep; 34(9):1090-1097. PubMed ID: 36044349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical Telemedicine for Veterans with Persistently Poor Diabetes Control: A Randomized Pilot Trial.
    Crowley MJ; Edelman D; McAndrew AT; Kistler S; Danus S; Webb JA; Zanga J; Sanders LL; Coffman CJ; Jackson GL; Bosworth HB
    Telemed J E Health; 2016 May; 22(5):376-84. PubMed ID: 26540163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Quality Performance Measures for Patients Receiving In-Person vs Telemedicine Primary Care in a Large Integrated Health System.
    Baughman DJ; Jabbarpour Y; Westfall JM; Jetty A; Zain A; Baughman K; Pollak B; Waheed A
    JAMA Netw Open; 2022 Sep; 5(9):e2233267. PubMed ID: 36156147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telemedicine and health access inequalities during the COVID-19 pandemic.
    Datta P; Eiland L; Samson K; Donovan A; Anzalone AJ; McAdam-Marx C
    J Glob Health; 2022 Dec; 12():05051. PubMed ID: 36462207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes Control in a Student-Run Free Clinic During the COVID-19 Pandemic.
    Simon ME; Reuter ZC; Fabricius MM; Hitchcock NM; Pierce RP
    J Community Health; 2022 Oct; 47(5):835-840. PubMed ID: 35788471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved outpatient medical visit compliance with sociodemographic discrepancies in vascular telehealth evaluations.
    Abou Ali AN; Abdul Malak OM; Hafeez MS; Habib S; Cherfan P; Salem KM; Hager E; Avgerinos E; Sridharan N
    J Vasc Surg; 2023 Apr; 77(4):1238-1244. PubMed ID: 36375724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial.
    Alessi J; de Oliveira GB; Franco DW; Becker AS; Knijnik CP; Kobe GL; Amaral BB; de Brito A; Schaan BD; Telo GH
    Acta Diabetol; 2021 Jul; 58(7):899-909. PubMed ID: 33723649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic.
    Gujral K; Van Campen J; Jacobs J; Kimerling R; Zulman DM; Blonigen D
    J Subst Use Addict Treat; 2023 Jul; 150():209067. PubMed ID: 37164153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic Review and Meta-Analysis of Telecoaching for Self-Care Management among Persons with Type 2 Diabetes Mellitus.
    Platini H; Lathifah A; Maulana S; Musthofa F; Amirah S; Abdurrahman MF; Komariah M; Pahria T; Ibrahim K; Lele JAJMN
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Ojo O; Wang XH; Ojo OO; Orjih E; Pavithran N; Adegboye ARA; Feng QQ; McCrone P
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.
    Kobe EA; Edelman D; Tarkington PE; Bosworth HB; Maciejewski ML; Steinhauser K; Jeffreys AS; Coffman CJ; Smith VA; Strawbridge EM; Szabo ST; Desai S; Garrett MP; Wilmot TC; Marcano TJ; Overby DL; Tisdale GA; Durkee M; Bullard S; Dar MS; Mundy AC; Hiner J; Fredrickson SK; Majette Elliott NT; Howard T; Jeter DH; Danus S; Crowley MJ
    Contemp Clin Trials; 2020 Nov; 98():106157. PubMed ID: 32971277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of characteristics of patients seen in a tertiary hospital diabetes telehealth service versus specialist face-to-face outpatients.
    Menon A; Gray LC; Fatehi F; Darssan D; Bird D; Bennetts D; Russell AW
    J Telemed Telecare; 2017 Dec; 23(10):842-849. PubMed ID: 28959908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS; West HM
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009613. PubMed ID: 28602020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The COVID-19 Pandemic and Access to Selected Ambulatory Care Services Among Populations With Severely Uncontrolled Diabetes and Hypertension in Massachusetts.
    Nielsen VM; Song G; Ojamaa LS; Blodgett RP; Rocchio CM; Pennock JN
    Public Health Rep; 2022; 137(2):344-351. PubMed ID: 35086370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.
    Onishi Y; Yoshida Y; Takao T; Tahara T; Kikuchi T; Kobori T; Kubota T; Shimmei A; Iwamoto M; Kasuga M
    J Diabetes Investig; 2022 Feb; 13(2):386-390. PubMed ID: 33728760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits.
    Herber E; Bondar A; Hockings J; Hermiller T; Russo-Alvarez G; Wang L; Schulz L
    J Am Pharm Assoc (2003); 2023; 63(4):1175-1179. PubMed ID: 37116796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.